Novamune inj. susp. (conc.) s.c. amp.

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Infectious Bursal Disease Virus (live, attenuated)

Available from:

Ceva Santé Animale SA-NV

ATC code:

QI01AD09

INN (International Name):

Avian Infectious Bronchitis Virus, Live, Attenuated

Pharmaceutical form:

Concentrate for suspension for injection

Composition:

Avian Infectious Bronchitis Virus, Live, Attenuated

Administration route:

Subcutaneous use

Therapeutic group:

poultry

Therapeutic area:

Avian Infectious Bursal Disease Virus (Gumboro Disease)

Product summary:

CTI code: 534062-04 - Pack size: 500 doses (2 (2) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 534062-03 - Pack size: 5 x 2000 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 534062-02 - Pack size: 5 x 1000 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 534062-01 - Pack size: 5 x 500 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 534062-08 - Pack size: 2000 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 534062-07 - Pack size: 1000 doses (5 (5) - Commercialisation status: YES - Delivery mode: Medical prescription; CTI code: 534062-06 - Pack size: 1000 doses (2 (2) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 534062-05 - Pack size: 500 doses (5 (5) - Commercialisation status: NO - Delivery mode: Medical prescription

Authorization status:

Commercialised: Yes

Authorization date:

2018-09-11